Holdings of Logos Global Management LP
56 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 53.7 % of the equity sleeve
Sector breakdown
- Health care 4.6 %
- Unattributed 95.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 55 | 1.8B $ | 95.91 % |
| 2 | FR | 1 | 75.2M $ | 4.09 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Revolution Medicines Inc | 2,000,000 | 194.5M $ | |
| 2 | Erasca Inc | 11,150,000 | 180.4M $ | |
| 3 | Ideaya Biosciences Inc | 3,450,000 | 115M $ | |
| 4 | Praxis Precision Medicines Inc | 285,000 | 91.8M $ | |
| 5 | CENTESSA PHARMACEUTICALS PLC | 2,125,000 | 84.4M $ | |
| 6 | Terns Pharmaceuticals Inc | 1,500,000 | 79.1M $ | |
| 7 | Abivax SA | 675,000 | 75.2M $ | |
| 8 | Tango Therapeutics Inc | 3,000,000 | 62.8M $ | |
| 9 | Cytokinetics Inc | 875,000 | 57.7M $ | |
| 10 | Olema Pharmaceuticals Inc | 3,208,875 | 47.8M $ | |
| 11 | United Therapeutics Corp | 80,000 | 47.4M $ | |
| 12 | Immunocore Holdings PLC | 1,500,000 | 45.2M $ | |
| 13 | Madrigal Pharmaceuticals Inc | 85,000 | 44.5M $ | |
| 14 | Rhythm Pharmaceuticals Inc | 450,000 | 39.1M $ | |
| 15 | CG oncology Inc | 575,000 | 38.9M $ | |
| 16 | Maze Therapeutics Inc | 1,235,000 | 36.9M $ | |
| 17 | Biogen Inc | 200,000 | 36.7M $ | |
| 18 | Disc Medicine Inc | 560,000 | 35.8M $ | |
| 19 | Dianthus Therapeutics Inc | 400,000 | 33.6M $ | |
| 20 | Ocular Therapeutix Inc | 3,850,000 | 32.6M $ | |
| 21 | Tyra Biosciences Inc | 850,000 | 32.6M $ | |
| 22 | Trevi Therapeutics Inc | 2,400,000 | 28.6M $ | |
| 23 | Immunovant Inc | 1,075,000 | 26.7M $ | |
| 24 | Arcus Biosciences Inc | 1,200,000 | 25.9M $ | |
| 25 | Dyne Therapeutics Inc | 1,400,000 | 25.4M $ | |
| 26 | Structure Therapeutics Inc | 500,000 | 24.1M $ | |
| 27 | LB Pharmaceuticals Inc | 915,000 | 22.6M $ | |
| 28 | Enliven Therapeutics Inc | 540,000 | 21.2M $ | |
| 29 | Design Therapeutics Inc | 1,950,000 | 20.7M $ | |
| 30 | Minerva Neurosciences Inc | 3,215,000 | 19.4M $ | |
| 31 | Mirum Pharmaceuticals Inc | 200,000 | 18.5M $ | |
| 32 | Vaxcyte Inc | 300,000 | 17.4M $ | |
| 33 | ACADIA Pharmaceuticals Inc | 750,000 | 16.7M $ | |
| 34 | Compass Therapeutics Inc | 3,150,000 | 16.7M $ | |
| 35 | Celldex Therapeutics Inc | 450,000 | 14.3M $ | |
| 36 | Janux Therapeutics Inc | 1,000,000 | 13.9M $ | |
| 37 | Vor BioPharma Inc | 750,000 | 13.4M $ | |
| 38 | ORIC Pharmaceuticals Inc | 950,000 | 12M $ | |
| 39 | Immix Biopharma Inc | 1,225,000 | 11.2M $ | |
| 40 | Tenax Therapeutics Inc | 625,000 | 10M $ | |
| 41 | Amylyx Pharmaceuticals Inc | 700,000 | 9.7M $ | |
| 42 | Soleno Therapeutics Inc | 250,000 | 8.4M $ | |
| 43 | ArriVent Biopharma Inc | 350,000 | 8.1M $ | |
| 44 | Relay Therapeutics Inc | 750,000 | 7.5M $ | |
| 45 | Corvus Pharmaceuticals Inc | 450,000 | 6.6M $ | |
| 46 | JADE BIOSCIENCES INC | 400,000 | 5.6M $ | |
| 47 | Verastem Inc | 1,000,000 | 5.3M $ | |
| 48 | AVALO THERAPEUTICS INC | 300,000 | 4.5M $ | |
| 49 | Unicycive Therapeutics Inc | 473,563 | 3.1M $ | |
| 50 | IBIO INC | 1,300,000 | 2.5M $ | |
| 51 | PALATIN TECHNOLOGIES INC | 140,000 | 2.4M $ | |
| 52 | Aclaris Therapeutics Inc | 500,000 | 1.9M $ | |
| 53 | VeraDermics Inc | 25,000 | 1.6M $ | |
| 54 | SENSEI BIOTHERAPEUTICS INC | 30,000 | 945.6K $ | |
| 55 | Septerna Inc | 23,548 | 565.9K $ | |
| 56 | Fractyl Health Inc | 1,000,000 | 457.8K $ | |